Table 6.
Sleep state test score for DHA/EPA and placebo treatment groups.
| Variable | Baseline | Week 12 | ||||
|---|---|---|---|---|---|---|
| DHA/EPA Group (n = 33) | Placebo Group (n = 33) | p Value | DHA/EPA Group (n = 32) | Placebo Group (n = 32) | p Value | |
| Sleep efficiency (%) | 95.6 ± 2.9 | 96.3 ± 3.1 | 0.401 | 96.0 ± 2.6 * | 93.7 ± 9.4 | 0.018 |
| Sleep latency (min) | 21.7 ± 12.1 | 20.9 ± 15.6 | 0.827 | 27.8 ± 13.5 | 21.5 ± 12.6 | 0.062 |
| Total sleep time (min) | 365.9 ± 63.9 | 384.0 ± 60.9 | 0.244 | 378.8 ± 90.4 | 400.6 ± 89.3 | 0.867 |
| Actual sleep time (min) | 351.7 ± 62.3 | 370.9 ± 58.4 | 0.202 | 364.2 ± 82.4 | 374.1 ± 68.2 | 0.468 |
| Average awakening length (min) | 14.2 ± 10.5 | 13.2 ± 12.8 | 0.715 | 14.6 ± 12.5 | 26.6 ± 53.9 | 0.134 |
| Average ratio of awakening (%) | 3.9 ± 2.9 | 3.2 ± 3.1 | 0.369 | 3.5 ± 2.5 * | 5.8 ± 9.4 | 0.018 |
* p < 0.05.